Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Yanlei Xu
Institution:
Nanjing University of Chinese Medicine
Observed institution:
Nanjing University of Chinese Medicine
ORCID:
0009-0002-5931-5253
Observed ORCID:
0009-0002-5931-5253
OpenAlex ID:
A5032953077
San Huang Decoction Targets Aurora Kinase A to Inhibit Tumor Angiogenesis in Breast Cancer
2020
·
Yanlei Xu
, Cong Wang
, et al.
·
Integrative Cancer Therapies
·
12
San Huang Decoction downregulates Aurora kinase A to inhibit breast cancer cell growth and enhance chemosenstivity to anti-tumor drugs
2016
·
Yanlei Xu
, Xu Chen
, et al.
·
Pathology - Research and Practice
·
12
Sanhuang Decoction Controls Tumor Microenvironment by Ameliorating Chronic Stress in Breast Cancer: A Report of Ninety Cases
2021
·
Ming Feng
, Huanhuan Wang
, et al.
·
Frontiers in Oncology
·
10
PDF
Mapping the knowledge landscape and research trends of artificial intelligence in breast cancer diagnosis and treatment: A bibliometric analysis
2026
·
Cong Wang
, Ke Hong
, et al.
·
Technology and Health Care
Chrysophanol attenuates breast cancer angiogenesis through blocking VEGFA/VEGFR2/ERK activation via inhibiting ACE2 ubiquitination
2026
·
Tong Zhao
, Luying Xu
, et al.
·
European Journal of Pharmacology
Serum levels of placenta growth factor, adiponectin and endothelin-1 correlate to the occurrence and outcomes of hypertensive disorders complicating pregnancy
2025
·
Shasha Liu
, Qianyu Lan
, et al.
·
Journal of Human Hypertension
The experimental study of Sanhuang antioxidant decoction based on Nrf - 2 /ARE pathway in order to inhibiting angiogenesis of breast cancer cell
2016
·
Zhang Xiao-qing
, Bian Weihe
, et al.
·
Lishizhen Medicine and Materia Medica Research
Show more works
View as search
Works count:
7
Citation count:
34
H-index:
3
I10-index:
3
Year
Topic
Type